NCT00000252View on ClinicalTrials.gov

Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 1994

Primary Completion Date

June 30, 1996

Study Completion Date

June 30, 1996

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

0% N2O

DRUG

10% N2O

DRUG

20% N2O

DRUG

30% N2O

DRUG

40% N2O

Trial Locations (1)

60637

University of Chicago, Anesthesia & Critical Care, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER

NCT00000252 - Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 | Biotech Hunter | Biotech Hunter